CGNNT(000881)
Search documents
中广核技(000881.SZ):2025年三季报净利润为-1.02亿元,同比亏损减少
Xin Lang Cai Jing· 2025-10-31 01:45
Core Insights - The company reported a total operating revenue of 4.065 billion yuan for Q3 2025, ranking 28th among disclosed peers [1] - The net profit attributable to shareholders was -102 million yuan, an increase of 32.53 million yuan compared to the same period last year [1] - The net cash inflow from operating activities was 38.87 million yuan [1] Financial Metrics - The latest debt-to-asset ratio is 44.49%, a decrease of 4.50 percentage points from the previous quarter and a decrease of 3.46 percentage points from the same period last year [3] - The latest gross profit margin is 13.47%, an increase of 0.07 percentage points from the previous quarter and an increase of 0.97 percentage points from the same period last year [3] - The latest return on equity (ROE) is -1.95%, an increase of 0.52 percentage points from the same period last year [3] - The diluted earnings per share are -0.11 yuan, an increase of 0.03 yuan compared to the same period last year [3] - The latest total asset turnover ratio is 0.38 times, ranking 88th among disclosed peers [3] - The latest inventory turnover ratio is 3.14 times [3] Shareholder Structure - The number of shareholders is 48,400, with the top ten shareholders holding 489 million shares, accounting for 51.77% of the total share capital [3] - The largest shareholder is China General Nuclear Technology Application Co., Ltd., holding 28.6% of shares [3] - Other significant shareholders include China Dalian International Economic and Technical Cooperation Group Co., Ltd. (12.5%) and Chen Xiaomin (4.24%) [3]
中广核核技术发展股份有限公司2025年第三季度报告
Shang Hai Zheng Quan Bao· 2025-10-30 23:15
Core Viewpoint - The company has disclosed its third-quarter financial report for 2025, ensuring the accuracy and completeness of the information provided [2][11]. Financial Data - The third-quarter financial report has not been audited [3][6]. - There are no adjustments or restatements of previous accounting data [3]. - The company has no non-recurring profit and loss items to report [3]. Board Meeting - The 31st meeting of the 10th Board of Directors was held on October 29, 2025, with all 9 directors present [8][9]. - The board approved the third-quarter report and several other resolutions, including the absorption merger of subsidiaries and the liquidation of a subsidiary [11][13][15]. Shareholder Information - The company has confirmed that there are no changes in the major shareholders or their holdings that would affect the report [5]. Regulatory Compliance - The board meeting and its resolutions comply with relevant laws and regulations [10]. - The company has revised several internal management systems, including those related to investor relations and compliance [17][18][20][22].
中广核技:10月29日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-10-30 17:57
每经头条(nbdtoutiao)——多地出现"负电价",既然卖电"不挣钱",为何电厂不愿停机? (记者 贾运可) 2025年1至6月份,中广核技的营业收入构成为:改性高分子材料占比82.38%,其他占比8.49%,电子加 速器及辐照加工占比8.4%,进出口贸易占比0.73%。 每经AI快讯,中广核技(SZ 000881,收盘价:8.09元)10月31日发布公告称,公司第十届第三十一次 董事会会议于2025年10月29日在深圳市福田区深南大道2002号中广核大厦北楼19层881会议室以现场结 合通讯表决方式召开。会议审议了《关于审批修订 <内部审计管理制度> 的议案》等文件。 ...
中广核技的前世今生:技术派掌舵,新材料营收占比超八成,核医疗拓展可期
Xin Lang Zheng Quan· 2025-10-30 16:04
Core Viewpoint - China General Nuclear Power Technology Co., Ltd. (CGN Tech) is a leading enterprise in non-power nuclear technology, focusing on accelerator manufacturing and irradiation processing services, with a strategic emphasis on its core business [1][5]. Financial Performance - For Q3 2025, CGN Tech reported revenue of 4.065 billion yuan, ranking 8th in the industry, significantly above the industry average of 1.994 billion yuan but far below the top competitor, Sinochem International, at 35.716 billion yuan [2]. - The company's net profit for the same period was -109 million yuan, placing it 74th in the industry, which is considerably lower than the industry average net profit of 74.438 million yuan [2]. - The main business composition includes new materials at 2.136 billion yuan (82.38%), with other segments contributing 220 million yuan (8.49%) and electronic accelerators and irradiation processing at 218 million yuan (8.40%) [2]. Financial Ratios - As of Q3 2025, CGN Tech's debt-to-asset ratio was 44.49%, down from 47.95% year-on-year, but still above the industry average of 34.74% [3]. - The gross profit margin for the same period was 13.47%, an increase from 12.50% year-on-year, yet still below the industry average of 19.93% [3]. Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 17.23% to 48,400, while the average number of circulating A-shares held per shareholder increased by 28.65% to 17,400 [5]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited and Southern CSI 1000 ETF, with notable changes in their holdings [5]. Business Highlights - CGN Tech is recognized as the only manufacturing champion in the domestic electronic accelerator sector, with a production capacity of 90 units per year and a 30% increase in accelerator sales expected in 2024 [6]. - The company is expanding its nuclear medicine sector with the proton therapy equipment and isotope production, with production expected to commence soon [5][6]. - Revenue projections for 2025 to 2027 are 6.760 billion yuan, 7.708 billion yuan, and 8.206 billion yuan, respectively, with net profits expected to rise from 55 million yuan in 2025 to 221 million yuan in 2027 [5][6].
中广核技(000881.SZ)发布前三季度业绩,归母净亏损1.02亿元
智通财经网· 2025-10-30 12:47
Core Viewpoint - China General Nuclear Power Technology Co., Ltd. (000881.SZ) reported a decline in revenue and a net loss for the first three quarters of 2025 [1] Financial Performance - The company's operating revenue for the first three quarters was 4.065 billion yuan, representing a year-on-year decrease of 8.81% [1] - The net loss attributable to shareholders of the listed company was 102 million yuan [1] - The net loss attributable to shareholders, excluding non-recurring gains and losses, was 127 million yuan [1] - The basic loss per share was 0.1077 yuan [1]
中广核技(000881) - 内部审计管理制度
2025-10-30 08:47
CGNNT 内部审计管理制度 版次:2 页:3/10 第一章 总 则 第一条 为规范公司内部审计工作,明确内部审计的宗旨、职责和权限,实现内部审计的 制度化和规范化,根据《中华人民共和国审计法》《审计署关于内部审计工作的规定》《中国内 部审计准则》《中央企业内部审计管理暂行办法》《关于深化中央企业内部审计监督工作的实施 意见》《党政主要领导干部和国有企事业单位主要领导人员经济责任审计规定》《深圳证券交易 所股票上市规则》等法律法规和行业准则,结合公司实际,制定本制度。 第二条 本制度适用于公司及各成员公司 第三条 本制度所称内部审计,是指对财务收支、经济活动、内部控制、风险管理实施独 立、客观的监督、评价和建议,以促进公司完善治理、实现目标的活动。其目标包括防止错误 和舞弊的发生,保护资产的安全和完整,确保公司各项规章制度与有关决议、可适用标准等得 到有效遵守,促进内部程序的合理性和资源利用的效率性,合理保证经营质量。 第四条 本制度相关的名词解释如下: (一)公司:指中广核核技术发展股份有限公司; (二)二级成员公司:指公司直接管理的成员公司 (三)成员公司:指公司直接、间接控股或实际管理的各级公司(含托管 ...
中广核技(000881) - 董事和高级管理人员买卖和持有公司股票管理制度
2025-10-30 08:47
CGNNT 董事和高级管理人员买卖和持有公司股票管理制度 版次:4 页:1/7 中广核核技术发展股份有限公司 制度流程 董事和高级管理人员买卖和持有公司股票管理制度 目录 第一章 总 则 .................................................... 2 第二章 买卖公司股票的禁止行为 ....................................2 第三章 信息申报与披露 ............................................3 第四章 股份持有及变动管理 ........................................5 第五章 责任追究 ................................................. 7 第六章 附则 ..................................................... 7 | | | 版次:4 | 页:2/7 | | --- | --- | --- | --- | | CGNNT | 董事和高级管理人员买卖和持有 ...
中广核技(000881) - 投资者关系管理制度
2025-10-30 08:47
CGNNT 投资者关系管理制度 版次:3 页:1/10 中广核核技术发展股份有限公司 制度流程 投资者关系管理制度 目 录 第一章 总则 ................................................... 2 第二章 投资者关系管理的基本原则和目的 ......................... 3 第三章 投资者关系管理的职责 ................................... 4 第四章 投资者关系管理的内容和工作方式 ......................... 5 第五章 投诉处理与责任追究 ..................................... 9 第六章 附 则 ................................................. 10 第一条 为使中广核核技术发展股份有限公司(以下简称"公司")严格遵循相关法律和 法规,规范公司投资者关系管理工作,加强公司与投资者及潜在投资者(以下统称"投资者") 之间的信息沟通,保护投资者合法权益,增进投资者对公司的了解及认同,促进公司和投资者 ...
中广核技(000881) - 合规管理制度
2025-10-30 08:47
| | | 版次:2 | 页:2/9 | | --- | --- | --- | --- | | CGNNT | 合规管理制度 | | | 第一章 总则 第一条 为深入贯彻习近平法治思想,落实全面依法治国战略部署,推动公司加强合规管 理,切实防控风险,保障深化改革与高质量发展,依据《中华人民共和国公司法》《中华人 民共和国企业国有资产法》《中央企业合规管理办法》等有关法律法规规定,制定本制度。 第二条 本制度适用于公司及各成员公司。 第三条 本制度相关名词含义解释如下: (一)合规:指企业经营管理行为和员工履职行为符合法律法规、监管规定、行业准则 和国际条约、规则,以及公司章程、相关规章制度等要求。 (二)合规风险:指企业及其员工在经营管理过程中因违规行为引发法律责任、造成经 济或声誉损失以及其他负面影响的可能性。 (三)合规管理:指企业以有效防控合规风险为目的,以提升依法合规经营管理水平为 导向,以企业经营管理行为和员工履职行为为对象,开展的包括建立合规制度、完善运行机 制、培育合规文化、强化监督问责等有组织、有计划的管理活动。 (四)公司:指中广核核技术发展股份有限公司。 (七)二级成员公司:指公司直接管 ...
中广核技(000881) - 2025 Q3 - 季度财报
2025-10-30 08:45
Financial Performance - The company's operating revenue for Q3 2025 was ¥1,471,564,333.98, a decrease of 9.72% compared to the same period last year[5]. - The net profit attributable to shareholders was a loss of ¥2,021,463.66, representing a significant increase in loss of 95.77% year-on-year[5]. - Total revenue for the current period was ¥4,064,849,904.19, a decrease of 8.8% compared to ¥4,457,630,998.85 in the previous period[23]. - Net profit for the current period was a loss of ¥108,992,455.75, compared to a loss of ¥128,834,128.16 in the previous period, showing an improvement of 15.0%[24]. - The company reported a total comprehensive loss of ¥106,902,170.34, compared to a loss of ¥135,554,727.64 in the previous period, indicating a 21.2% improvement[25]. Cash Flow - The net cash flow from operating activities was ¥38,870,547.47, down 69.89% compared to the previous year[5]. - Operating cash inflow totaled $3,877,793,462.38, a decrease of 14.2% from $4,520,184,374.94 in the previous period[27]. - Operating cash outflow amounted to $3,838,922,914.91, down 12.6% from $4,391,074,901.08 year-over-year[28]. - Cash flow from investing activities showed a net outflow of $662,998,093.40, contrasting with a net inflow of $312,039,885.41 previously[29]. - Cash inflow from financing activities reached $2,823,136,147.12, an increase from $2,242,323,051.60 in the last period[29]. - Net cash flow from financing activities was $291,296,481.79, up from $241,724,174.21 year-over-year[29]. - The ending cash and cash equivalents balance was $1,115,597,323.91, down from $1,702,278,817.22 in the previous period[29]. - Cash paid for the repayment of debts was $2,400,566,424.96, an increase from $1,850,005,507.29 in the prior period[29]. Assets and Liabilities - Total assets at the end of the reporting period were ¥10,683,380,307.28, a decrease of 0.18% from the end of the previous year[5]. - The total assets decreased slightly to ¥10,683,380,307.28 from ¥10,702,263,483.90, a decline of 0.2%[22]. - Current liabilities increased to ¥3,823,813,859.98 from ¥3,300,237,661.42, an increase of 15.8%[22]. - Non-current liabilities decreased significantly to ¥929,149,219.50 from ¥1,853,701,743.59, a reduction of 50.0%[22]. - The company's total liabilities increased by 286.19% for current liabilities due to an increase in long-term borrowings due within one year[9]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 48,440[16]. - The largest shareholder, China General Nuclear Power Corporation, holds 28.67% of shares, totaling 271,070,498 shares[16]. - The company has a total of 12.58% of shares held by China Dalian International Economic and Technical Cooperation Group, amounting to 118,914,273 shares[16]. - The number of shares held by the top 10 shareholders includes 242,512,474 unrestricted shares held by China General Nuclear Power Technology Application Co., Ltd.[17]. - The total number of shares pledged by major shareholders includes 118,914,273 shares by China Dalian International Economic and Technical Cooperation Group[16]. Operational Metrics - The company's basic earnings per share were -¥0.0021, reflecting a 95.84% increase in loss compared to the same period last year[5]. - Basic earnings per share for the current period was -0.1077, an improvement from -0.1421 in the previous period[25]. - Research and development expenses were ¥138,124,253.32, down from ¥151,996,515.86, reflecting a decrease of 9.2%[23]. - Total operating costs decreased to ¥4,241,335,113.19 from ¥4,715,082,492.09, reflecting a reduction of 10.0%[23]. - Investment income showed a significant decline of 111.69%, resulting in a loss of ¥3,475,416.63, attributed to the absence of equity asset sales[11]. Other Financial Information - The company reported a total of ¥11,136,995.92 in non-recurring gains and losses for the current period[6]. - The company's cash and cash equivalents at the end of the period amount to ¥1,543,578,957.99, an increase from ¥1,490,786,138.55 at the beginning of the period[20]. - Accounts receivable decreased to ¥2,014,636,434.12 from ¥2,185,366,416.81, reflecting a decline of approximately 7.8%[20]. - Inventory increased to ¥1,166,010,667.72 from ¥1,077,521,780.98, representing an increase of about 8.2%[20]. - Non-current assets total ¥4,436,463,265.07, slightly up from ¥4,413,515,045.35, indicating a growth of approximately 0.5%[20]. Audit Information - The company did not undergo an audit for the third quarter financial report[30].